Equity Analysis /
United States of America

US : Aerie Pharmaceuticals, Inc. - AERI | Positive Initial Phase III For Netarsudil Sets AERI Up to ROCK The Japanese Market

    Michael Parolari
    Michael Parolari

    Research Associate

    CGS-CIMB
    13 October 2021
    Published by